Pre-market
Loading markets…

Advertisement

Stocks

What's Going On With Canfor Corporation Stock Tuesday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:CFP.TO

Follow CFP

Photos provided by Pexels

Canfor Corporation's stock has seen a notable decline this week amidst key announcements and market reactions.

Canfor Corporation (CFP.TO) has had a tough week, with its stock down 7.32% over the past week, even though it has gained 20.95% year-to-date. Recent developments regarding its third-quarter results and strategic moves have caught the attention of investors and analysts alike.

Advertisement

Canfor Corporation

CFP.TO

Full stock page →

CFP.TO

Canfor Corporation

Source:WealthAwesomeWealthAwesome
↑ $1.69 (12.60%)
120 day period
$11.77$14.00$16.24Apr 14Jul 9Oct 5

Market cap

$1.75B

52W high

$16.59

52W low

$10.86

1W change

-7.32%

Beta

1.47

Analyst Price Targets

Based on analyst covering CFP · as of Sep 21, 2026

📈

Wall Street analysts forecast CFP stock price to rise 18.5% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$17.71

+18.5% Upside

Previously C$17.14 on Sep 17, 2026

Current Price

C$14.95

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CFP's historical volatility

HistoricalForecast68%95%
C$11.89C$14.94C$17.98C$21.02C$24.06C$27.10TodayMay 27Jul 31Oct 5Nov 17Dec 31Feb 12

30-Day Vol

32.0%

Annualized

90-Day Vol

35.2%

Annualized

Trend (90d)

+48.6%

Annualized drift

90d Mean

C$17.96

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$16.00C$14.33 – C$17.86
60 trading daysC$16.95C$14.51 – C$19.81
90 trading daysC$17.96C$14.84 – C$21.74

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Keep an eye on Canfor's upcoming conference call and consider the implications of its recent business decisions, especially the PinkWood deal, as these could significantly impact future performance.

Canfor's stock closed at C$15.10, down 7.32% this week.

The stock's recent volatility reflects investor uncertainty, particularly with a 1D price change of 0.00% despite significant weekly losses.

Bull case

Analysts are optimistic about Canfor, with an average target of C$17.71, indicating potential upside from current levels. The company’s strategic initiatives, including its recent acquisition, may set it up for a rebound.

Bear case

However, Canfor faces challenges, including a negative profit margin and declining EPS, which could raise concerns about its financial health and sustainability in the current market environment.

Price Action Overview

Canfor Corporation's stock closed at C$15.10, showing no change for the day. Despite the 7.32% decline over the past week, the stock remains up 20.95% year-to-date, suggesting that there has been overall positive momentum in 2023, even with recent struggles.

Advertisement

Recent Company News

This week, Canfor announced a conference call scheduled for October 1, 2026, to discuss its third-quarter results. The company has also been in the news regarding its recent acquisition of PinkWood, raising questions about whether the market rebound still presents a buying opportunity for investors.

Technical Picture

From a technical perspective, Canfor’s stock currently trades above its 50-day moving average of C$15.03, indicating a slight bullish sentiment. The 200-day moving average stands at C$13.78, suggesting a solid long-term trend. The stock has a beta of 1.47, indicating higher volatility compared to the broader market. The 52-week range of C$10.86 to C$16.59 reflects a 74% movement within this range, highlighting the stock's potential for significant price swings.

Insider Activity

No recent insider activity has been reported for Canfor Corporation, which may suggest stability in management and ownership structures at this time.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 6, 2026
Last Updated: October 6, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement